Retatrutide is a next-generation metabolic peptide targeting GLP-1, GIP and glucagon receptors simultaneously. It is currently studied for its effects on appetite regulation, metabolic signalling and fat oxidation pathways. Retatrutide activates three metabolic receptors simultaneously. GLP-1 receptor activation slows gastric emptying and reduces appetite signalling. GIP receptor activation improves glucose-dependent insulin response. Glucagon receptor activation promotes hepatic lipid oxidation and increased energy mobilisation.

Key Benefits
-Appetite suppression via GLP-1 signalling
-Improved insulin sensitivity
-Increased fat oxidation
-Enhanced metabolic efficiency

Results & Research
Clinical research subjects demonstrated significant reductions in body weight, improved metabolic markers and increased fat metabolism compared with traditional single-receptor metabolic compounds. Retatrutide (LY3437943) is currently being studied in Phase II clinical trials conducted by Eli Lilly. Published data in the New England Journal of Medicine demonstrated dose-dependent weight reductions approaching 24% over 48 weeks.

Tirzepatide is a peptide that acts on GIP and GLP-1 receptors and has been studied for its role in appetite regulation, glucose metabolism, and insulin sensitivity. The activity of incretin pathways is associated with the regulation of satiety, gastrointestinal motility, and metabolic regulation.

Key Benefits
-Dual GIP/GLP-1 pathway research
-Appetite regulation
-Glucose metabolism
-Satiety&Metabolic research

Results & Research
Tirzepatide is one of the extensively studied compounds in research related to weight management and metabolic syndrome.

AOD-9604 is a peptide fragment derived from the C-terminal region of human growth hormone, primarily studied for mechanisms related to lipid metabolism. It has been studied in relation to lipolysis and the inhibition of lipogenesis, without focusing on the growth-promoting domains of hGH.

Key Benefits
-Lipid metabolism research
-Lipolysis research
-Lipogenesis research
-Body composition studies
-Metabolic pathway research

Results & Research
AOD-9604 has been studied in the areas of fat metabolism and body composition, particularly mechanisms related to the breakdown and accumulation of fat.

Cagrilintide is a long-acting amylin analogue studied for its role in satiety regulation through amylin receptor pathways, which differ from the mechanisms of GLP-1. Research has explored its use in combination with GLP-1 receptor agonists to investigate effects on appetite and metabolic regulation.

Key Benefits
-Satiety pathway research
-Amylin receptor research
-Appetite regulation
-Metabolic research
-Combination pathway studies

Results & Research
Research has focused on Cagrilintide as a pathway that functions differently from incretin-based compounds and can be investigated in combination research approaches.

5-Amino-1MQ is a small-molecule compound that acts as a selective NNMT inhibitor and has been studied in relation to cellular metabolism and lipid metabolism. Unlike many peptides, it is a small-molecule compound that has been investigated for its potential role in metabolic regulation and the preservation of lean mass.

Key Benefits
-NNMT pathway research
-Cellular metabolism
-Lipid metabolism
-Body composition research
-Lean mass research

Results & Research
Research has focused on the role of NNMT inhibition in metabolic function and changes in fat-cell metabolism.

MOTS-C is a mitochondrial-derived peptide encoded by mitochondrial DNA and has been studied in relation to the AMPK pathway and cellular metabolism. Research has focused on glucose utilization, metabolic function, muscle metabolism, and longevity biomarkers.

Key Benefits
-AMPK pathway research
-Cellular metabolism
-Glucose utilization
-Muscle metabolism
-Longevity research

Results & Research
MOTS-C has been studied in the context of metabolic aging and cellular energy regulation, particularly the relationship between mitochondria and metabolism.

Glutathione is an intracellular tripeptide that plays an important role in antioxidant defense and the management of oxidative stress within cells. The document also discusses research related to free-radical neutralization, liver detoxification support, and skin pigmentation pathways.

Key Benefits
-Antioxidant research
-Oxidative stress research
-Cellular protection
-Free-radical research
-Skin pigmentation research

Results & Research
Glutathione has been extensively studied in the context of cellular antioxidant systems and mechanisms associated with oxidative stress.

GHK-Cu is a naturally occurring copper-complexed tripeptide associated with collagen and elastin production, as well as extracellular matrix remodeling. It has been studied in the areas of skin rejuvenation, wound-healing research, and post-microneedling recovery.

Key Benefits
-Collagen research
-Elastin research
-Extracellular matrix remodeling
-Skin regeneration research
-Anti-inflammatory research

Results & Research
GHK-Cu has received significant research interest in dermatological applications and extracellular matrix remodeling.

SS-31, also known as Elamipretide, is a mitochondria-targeting peptide that has been studied in relation to mitochondrial structure protection and antioxidant defense. This compound can bind to cardiolipin in the inner mitochondrial membrane and has been investigated in relation to mitochondrial function and ATP synthesis.

Key Benefits
-Mitochondrial research
-Antioxidant defense
-ATP synthesis research
-Cellular energy research
-Mitochondrial structure research

Results & Research
SS-31 research focuses on the mitochondrial level, particularly mitochondrial membrane structure, reactive oxygen species (ROS), and cellular energy production.